Furthermore, our data show that the pre-treatment of PCa cells with a CXCR4 antagonist, AMD3100, neutralizes the effect of CXCL12 and thus restores the stabilization of microtubules (Figure 3A). The gene discussed is CXCR4; the disease is posterior cortical atrophy.